Form CORRESP - Correspondence:
SEC Accession No. 0001213900-14-002504
Filing Date
2014-04-16
Accepted
2014-04-16 12:53:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 13994
  Complete submission text file 0001213900-14-002504.txt   14957
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 6770 Blank Checks